Literature DB >> 18477847

Melkersson-Rosenthal syndrome and acquired C1 inhibitor deficiency.

F Masson1, S Barete, V Frémeaux-Bacchi, H Szpirglas, S Agbo-Godeau, O Chosidow, J C Piette, C Francès.   

Abstract

BACKGROUND: Melkersson-Rosenthal syndrome (MRS) is a rare disease whose full-blown form is characterized by orofacial swelling, facial palsy and lingua plicata.
OBJECTIVE: To investigate the complement system as well as its role in patients with MRS.
METHODS: Seven patients presenting at this hospital between November 2002 and May 2003 and meeting the diagnostic criteria according to Hornstein were evaluated retrospectively. The investigations included clinical signs, an analysis of the complement system including levels of CH50, C3, C4, C1 inhibitor (INH) functions and C1-INH antigen detection.
RESULTS: Two female patients showed isolated low levels of functional C1-INH as determined by duplicate tests. Both patients took estrogen-progestin contraceptives.
CONCLUSION: Since deficiency in plasma protease C1-INH is known to lead to recurrent angioedema, we hypothesize that low levels of functional C1-INH may have contributed to the orofacial swelling in the 2 patients. (c) 2008 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18477847     DOI: 10.1159/000131169

Source DB:  PubMed          Journal:  Dermatology        ISSN: 1018-8665            Impact factor:   5.366


  3 in total

1.  The Melkersson-Rosenthal syndrome: a retrospective study of biopsied cases.

Authors:  Martha K Elias; Farrah J Mateen; Catherine R Weiler
Journal:  J Neurol       Date:  2012-07-27       Impact factor: 4.849

2.  Recurrent Facial Palsy and Electrophysiological Findings in Oligosymptomatic Melkersson Rosenthal Syndrome.

Authors:  Arushi Gahlot Saini; Naveen Sankhyan; Hansashree Padmanabh; Ashim Das; Pratibha Singhi
Journal:  Indian J Pediatr       Date:  2016-05-11       Impact factor: 5.319

3.  Melkerrson-Rosenthal Syndrome, a rare case report of chronic eyelid swelling.

Authors:  Babita Kajal; John Harvey; Salem Alowami
Journal:  Diagn Pathol       Date:  2013-11-13       Impact factor: 2.644

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.